{
    "nct_id": "NCT04099992",
    "official_title": "Sympatho-inhibition with Mindfulness in Chronic Kidney Disease (MIND-CKD)",
    "inclusion_criteria": "* stages III and IV CKD as defined by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation\n* stable renal function (no greater than a decline of eGFR of 1 cc/min/1.73 m2 per month over the prior 3 months)\nHealthy volunteers allowed\nMust have minimum age of 40 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* severe CKD (eGFR<15 cc/min)\n* diabetic neuropathy\n* autonomic dysfunction\n* any serious disease that might influence survival\n* anemia with hemoglobin <10 g/dL\n* treatment with central α-agonists or monoamine oxidase (MAO) inhibitors\n* myocardial infarction or cerebrovascular accident within the past 6 months\n* uncontrolled hypertension (BP≥170/100 mm Hg)\n* low BP (BP<100/50 mm Hg)\n* bradycardia (HR<55 beats/min)\n* ongoing drug or alcohol abuse (defined as >2 drinks/day in men, and >1 drink/day in women)\n* surgery within the past 3 months\n* adjustment of antihypertensive medications within the past month\n* pregnancy or plans to become pregnant\n* psychosis\n* suicidal ideation\n* implanted electronic or metallic device such as a pacemaker\n* implanted hearing aid, bone plate, carotid stent, bone screw at or near the neck\n* carotid atherosclerosis\n* concurrent use of another stimulating device such as a transcutaneous electrical nerve stimulation (TENS) unit",
    "miscellaneous_criteria": ""
}